Mabion
  • Company
    • About us
      • History
      • Leaderships
      • Team
      • EU grants
      • Requests for Proposal
      • Sustainability – ESG
      • Bussines strategy
      • Quality policy
      • Virtual Tour
    • Investors
      • Corporate documents
      • Shareholders and shares
      • Periodic reports
      • Current reports
      • Sustainability reports
      • Corporate governance at Mabion
      • Financial data
      • For Investors
      • Calendar
  • Resources
    • Science Hub
    • Press releases
    • News
    • Events
    • Media kit
  • Services
    • Process Development
    • Analytics 
    • Drug Substance Manufacturing
  • Contact
    • Contact form
    • Contact for investors
    • Contact for media
    • Careers
  • Science News
  • Resources

Drug substance

PD-1-Antibody-Development-Programs-for-Cancer-Immunotherapy

PD-1 Antibody Development Programs for Cancer Immunotherapy

Bispecific antibody, Cancer, Drug substance, Manufacturing, Monoclonal antibody
High-yield Monoclonal Antibodies Manufacturing Platform Approach cover

High-yield mAbs Manufacturing Platform Approach

Drug substance, Mabion, Manufacturing, Monoclonal antibody
Robust scale down models for reliable bioprocess scale up

Robust Scale-down Model for Reliable Upstream Bioprocessing Scale-up

Drug substance, GMP, Mabion, Manufacturing
bioprocess optimization

Bioprocess Optimization Across Upstream and Downstream Processing

Drug development, Drug product, Drug substance, Manufacturing
Mass spectrometry in biopharmaceutical research.

Mass Spectrometry in Peptide and Protein Analysis

Analytics, Drug substance, Proteins
Protein Vaccine Production

Mammalian Cell Lines as a Platform for Protein Vaccine Production

Cell culture, Drug substance, Manufacturing, Proteins, Vaccines
Host Cell Proteins

Qualitative Analysis of Host Cell Proteins using Mass Spectrometry

Analytics, Drug development, Drug product, Drug substance
Bioprocess operation modes. Bioreactors used in pharmaceutical biotechnology.

Bioprocess Operation Modes and Advanced Bioreactor Technology

Cell culture, Drug substance, Manufacturing
optimal CHO cell culture upstream process

Metabolite and nutrient analysis as crucial components for optimal CHO cell culture upstream process

Cell culture, Drug substance, Manufacturing
1 2 Next

Contact

Find out how we may support your business.

bd@mabion.eu

Mabion

gen. Mariana Langiewicza 60
95-050 Konstantynów Łódzki
Poland

+48 42 207 78 90

    Mabion
    • Privacy policy
    • CDMO
    • Media kit
    • Press releases
    • Events

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. HTML Sitemap

    Powered by

    Veneo